{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T14:28:32Z","timestamp":1787236112407,"version":"build-2736575974"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2015,2,26]],"date-time":"2015-02-26T00:00:00Z","timestamp":1424908800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1007\/s00520-015-2635-7","type":"journal-article","created":{"date-parts":[[2015,2,24]],"date-time":"2015-02-24T23:12:44Z","timestamp":1424819564000},"page":"1459-1471","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":41,"title":["Management of the extravasation of anti-neoplastic agents"],"prefix":"10.1007","volume":"23","author":[{"name":"in cooperation with the Comit\u00e9 de l\u2019\u00e9volution de la pratique des soins pharmaceutiques (CEPSP) and the Comit\u00e9 de l\u2019\u00e9volution des pratiques en oncologie (CEPO)","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Boulanger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Ducharme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Dufour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Fortier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Almanric","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,2,26]]},"reference":[{"issue":"1 Suppl","key":"2635_CR1","first-page":"S1","volume":"341","author":"Infusion Nurses Society","year":"2011","unstructured":"Infusion Nurses Society (2011) Infusion nursing standards of practice. J Infus Nurs 341(1 Suppl):S1\u2013S110","journal-title":"J Infus Nurs"},{"issue":"4","key":"2635_CR2","doi-asserted-by":"crossref","first-page":"185","DOI":"10.5694\/j.1326-5377.1988.tb112811.x","volume":"148","author":"K Cox","year":"1988","unstructured":"Cox K, Stuart-Harris R, Abdini G, Grygiel J, Raghavan D (1988) The management of cytotoxic-drug extravasation: guide-lines drawn up by a working party for the Clinical Oncological Society of Australia. Med J Aust 148(4):185\u2013189","journal-title":"Med J Aust"},{"issue":"3","key":"2635_CR3","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.soncn.2007.05.003","volume":"23","author":"L Schulmeister","year":"2007","unstructured":"Schulmeister L (2007) Extravasation management. Semin Oncol Nurs 23(3):184\u2013190. doi: 10.1016\/j.soncn.2007.05.003","journal-title":"Semin Oncol Nurs"},{"issue":"3","key":"2635_CR4","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.soncn.2006.04.007","volume":"22","author":"PH Viale","year":"2006","unstructured":"Viale PH (2006) Chemotherapy and cutaneous toxicities: implications for oncology nurses. Semin Oncol Nurs 22(3):144\u2013151. doi: 10.1016\/j.soncn.2006.04.007","journal-title":"Semin Oncol Nurs"},{"issue":"11","key":"2635_CR5","doi-asserted-by":"crossref","first-page":"2851","DOI":"10.1200\/JCO.1995.13.11.2851","volume":"13","author":"G Bertelli","year":"1995","unstructured":"Bertelli G, Gozza A, Forno GB, Vidili MG, Silvestro S, Venturini M, Del Mastro L, Garrone O, Rosso R, Dini D (1995) Topical dimethylsulfoxide for the prevention of soft tissue injury after extravasation of vesicant cytotoxic drugs: a prospective clinical study. J Clin Oncol 13(11):2851\u20132855","journal-title":"J Clin Oncol"},{"key":"2635_CR6","unstructured":"EONS (2007) Extravasation guidelines, http:\/\/www.cancernurse.eu\/documents\/EONSClinicalGuidelinesSection6-en.pdf#search \u00bc. Accessed October 2013"},{"issue":"9","key":"2635_CR7","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1002\/1097-0142(19820501)49:9<1796::AID-CNCR2820490911>3.0.CO;2-M","volume":"49","author":"DL Larson","year":"1982","unstructured":"Larson DL (1982) Treatment of tissue extravasation by antitumor agents. Cancer 49(9):1796\u20131799","journal-title":"Cancer"},{"issue":"1","key":"2635_CR8","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.soncn.2010.11.010","volume":"27","author":"L Schulmeister","year":"2011","unstructured":"Schulmeister L (2011) Extravasation management: clinical update. Semin Oncol Nurs 27(1):82\u201390. doi: 10.1016\/j.soncn.2010.11.010","journal-title":"Semin Oncol Nurs"},{"key":"2635_CR9","unstructured":"HYCCN (2013) Guidelines for the management of chemotherapy extravasation in adults. http:\/\/www.hyccn.nhs.uk\/Downloads\/HYCCN%20guidelines%20for%20the%20management%20of%20chemotherapy%20extravasation%20v1.4%202011.pdf . Accessed 17 October 2013"},{"issue":"4 Suppl","key":"2635_CR10","first-page":"305S","volume":"102","author":"DJ Cook","year":"1992","unstructured":"Cook DJ, Guyatt GH, Laupacis A, Sackett DL (1992) Rules of evidence and clinical recommendations on the use of antithrombotic agents. Chest 102(4 Suppl):305S\u2013311S","journal-title":"Chest"},{"issue":"6","key":"2635_CR11","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1188\/06.ONF.1134-1141","volume":"33","author":"C Sauerland","year":"2006","unstructured":"Sauerland C, Engelking C, Wickham R, Corbi D (2006) Vesicant extravasation part I: mechanisms, pathogenesis, and nursing care to reduce risk. Oncol Nurs Forum 33(6):1134\u20131141. doi: 10.1188\/06.ONF. 1134-1141","journal-title":"Oncol Nurs Forum"},{"issue":"4","key":"2635_CR12","doi-asserted-by":"crossref","first-page":"245","DOI":"10.2165\/00002018-199512040-00004","volume":"12","author":"G Bertelli","year":"1995","unstructured":"Bertelli G (1995) Prevention and management of extravasation of cytotoxic drugs. Drug Saf 12(4):245\u2013255","journal-title":"Drug Saf"},{"issue":"6","key":"2635_CR13","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1093\/annonc\/mdh214","volume":"15","author":"RA Ener","year":"2004","unstructured":"Ener RA, Meglathery SB, Styler M (2004) Extravasation of systemic hemato-oncological therapies. Ann Oncol 15(6):858\u2013862","journal-title":"Ann Oncol"},{"issue":"1","key":"2635_CR14","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/0268-960X(90)90015-K","volume":"4","author":"RT Dorr","year":"1990","unstructured":"Dorr RT (1990) Antidotes to vesicant chemotherapy extravasations. Blood Rev 4(1):41\u201360","journal-title":"Blood Rev"},{"issue":"9","key":"2635_CR15","first-page":"3680","volume":"6","author":"SW Langer","year":"2000","unstructured":"Langer SW, Sehested M, Jensen PB (2000) Treatment of anthracycline extravasation with dexrazoxane. Clin Cancer Res 6(9):3680\u20133686","journal-title":"Clin Cancer Res"},{"issue":"2 Suppl 5","key":"2635_CR16","first-page":"4","volume":"25","author":"E Raymond","year":"1998","unstructured":"Raymond E, Faivre S, Woynarowski JM, Chaney SG (1998) Oxaliplatin: mechanism of action and antineoplastic activity. Semin Oncol 25(2 Suppl 5):4\u201312","journal-title":"Semin Oncol"},{"issue":"1","key":"2635_CR17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/00015458.2013.11680876","volume":"113","author":"M Doornaert","year":"2013","unstructured":"Doornaert M, Monstrey S, Roche N (2013) Extravasation injuries: current medical and surgical treatment. Acta Chir Belg 113(1):1\u20137","journal-title":"Acta Chir Belg"},{"key":"2635_CR18","volume-title":"Chemotherapy extravasation guideline","author":"West of Scotland Cancer Advisory Network Clinical Leads Group (WOSCAN)","year":"2009","unstructured":"West of Scotland Cancer Advisory Network Clinical Leads Group (WOSCAN) (2009) Chemotherapy extravasation guideline. WOSCAN, Glasgow"},{"key":"2635_CR19","unstructured":"GONG (2007) Assessment , prevention and management of extravasation of cytotoxic medications. http:\/\/www.gha.net.au\/uploadlibrary\/393586908extravasation_guidelines0907.pdf . Accessed 11 October 2013. 8 p"},{"issue":"1","key":"2635_CR20","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1053\/j.seminoncol.2005.11.007","volume":"33","author":"TV Goolsby","year":"2006","unstructured":"Goolsby TV, Lombardo FA (2006) Extravasation of chemotherapeutic agents: prevention and treatment. Semin Oncol 33(1):139\u2013143. doi: 10.1053\/j.seminoncol.2005.11.007","journal-title":"Semin Oncol"},{"issue":"3","key":"2635_CR21","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1053\/jpon.2000.8063","volume":"17","author":"E Kassner","year":"2000","unstructured":"Kassner E (2000) Evaluation and treatment of chemotherapy extravasation injuries. J Pediatr Oncol Nurs 17(3):135\u2013148. doi: 10.1053\/jpon.2000.8063","journal-title":"J Pediatr Oncol Nurs"},{"issue":"Suppl 3","key":"2635_CR22","doi-asserted-by":"crossref","first-page":"iii26","DOI":"10.1093\/annonc\/mdg744","volume":"14","author":"DL Schrijvers","year":"2003","unstructured":"Schrijvers DL (2003) Extravasation: a dreaded complication of chemotherapy. Ann Oncol: Off J Eur Soc Med Oncol\/ESMO 14(Suppl 3):iii26\u2013iii30","journal-title":"Ann Oncol: Off J Eur Soc Med Oncol\/ESMO"},{"issue":"5","key":"2635_CR23","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.ejon.2012.09.004","volume":"16","author":"JA Perez Fidalgo","year":"2012","unstructured":"ESMO-EONS, Perez Fidalgo JA, Garcia Fabregat L, Cervantes A, Margulies A, Vidall C, Roila F (2012) Management of chemotherapy extravasation: ESMO\u2013EONS clinical practice guidelines. Eur J Oncol Nurs: Off J Eur Oncol Nurs Soc 16(5):528\u2013534","journal-title":"Eur J Oncol Nurs: Off J Eur Oncol Nurs Soc"},{"key":"2635_CR24","unstructured":"Polovich M, Whitford J, Olsen M (92009) Chemotherapy and Biotherapy Guidelines and Recommendations for Practice (3rd ed.). Oncology Nursing Society"},{"issue":"3","key":"2635_CR25","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1159\/000348524","volume":"36","author":"M Wit De","year":"2013","unstructured":"De Wit M, Ortner P, Lipp HP, Sehouli J, Untch M, Ruhnke M, Mayer-Steinacker R, Bokemeyer C, Jordan K (2013) Management of cytotoxic extravasation\u2014ASORS expert opinion for diagnosis, prevention and treatment. Onkologie 36(3):127\u2013135. doi: 10.1159\/000348524","journal-title":"Onkologie"},{"issue":"4","key":"2635_CR26","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.annemergmed.2010.05.026","volume":"57","author":"L Schulmeister","year":"2011","unstructured":"Schulmeister L, Pollack CV Jr (2011) Images in emergency medicine. Swollen hand. Anthracycline chemotherapy extravasation. Ann Emerg Med 57(4):417\u2013422. doi: 10.1016\/j.annemergmed.2010.05.026","journal-title":"Ann Emerg Med"},{"key":"2635_CR27","unstructured":"BCCA (2012) Prevention and management of extravasation of chemotherapy. http:\/\/www.bccancer.bc.ca\/NR\/rdonlyres\/B10C0DC3-D799-45E8-8A61-A93F00906737\/59243\/III_20_ExtravasationManagement_1Jun2013.pdf . Accessed 11 October 2013"},{"issue":"3","key":"2635_CR28","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0305-7372(81)80017-5","volume":"8","author":"RJ Spiegel","year":"1981","unstructured":"Spiegel RJ (1981) The acute toxicities of chemotherapy. Cancer Treat Rev 8(3):197\u2013207","journal-title":"Cancer Treat Rev"},{"issue":"5","key":"2635_CR29","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1097\/00000658-197511000-00003","volume":"182","author":"P Yosowitz","year":"1975","unstructured":"Yosowitz P, Ekland DA, Shaw RC, Parsons RW (1975) Peripheral intravenous infiltration necrosis. Ann Surg 182(5):553\u2013556","journal-title":"Ann Surg"},{"issue":"9","key":"2635_CR30","first-page":"1516","volume":"40","author":"JD Hirsh","year":"1983","unstructured":"Hirsh JD, Conlon PF (1983) Implementing guidelines for managing extravasation of antineoplastics. Am J Hosp Pharm 40(9):1516\u20131519","journal-title":"Am J Hosp Pharm"},{"issue":"1","key":"2635_CR31","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0305-7372(80)80023-5","volume":"7","author":"RJ Ignoffo","year":"1980","unstructured":"Ignoffo RJ, Friedman MA (1980) Therapy of local toxicities caused by extravasation of cancer chemotherapeutic drugs. Cancer Treat Rev 7(1):17\u201327","journal-title":"Cancer Treat Rev"},{"key":"2635_CR32","unstructured":"Association des pharmaciens des \u00e9tablissements de sant\u00e9 du Qu\u00e9bec (APES) (2003) Recueil d\u2019informations pharmaceutiques en oncologie. Montr\u00e9al, Qc : APES; 2003. http:\/\/guide.opq.org\/documents\/GuideCompletOncologie%20APES200310pdf.pdf . Accessed 11 November 2013"},{"issue":"4","key":"2635_CR33","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1097\/NAN.0b013e3181aac042","volume":"32","author":"D Doellman","year":"2009","unstructured":"Doellman D, Hadaway L, Bowe-Geddes LA, Franklin M, LeDonne J, Papke-O'Donnell L, Pettit J, Schulmeister L, Stranz M (2009) Infiltration and extravasation: update on prevention and management. J Infus Nurs 32(4):203\u2013211. doi: 10.1097\/NAN.0b013e3181aac04200129804-200907000-00010","journal-title":"J Infus Nurs"},{"key":"2635_CR34","unstructured":"Rapid Aid Ltd (2013) http:\/\/rapidaid.com\/home\/products\/index.html . Accessed 6 January 2014"},{"issue":"2","key":"2635_CR35","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1097\/00000421-200304000-00003","volume":"26","author":"AK Bozkurt","year":"2003","unstructured":"Bozkurt AK, Uzel B, Akman C, Ozguroglu M, Molinas Mandel N (2003) Intrathoracic extravasation of antineoplastic agents: case report and systematic review. Am J Clin Oncol 26(2):121\u2013123. doi: 10.1097\/01.COC.0000017088.74592.96","journal-title":"Am J Clin Oncol"},{"issue":"6","key":"2635_CR36","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1188\/06\/ONF.1143-1150","volume":"33","author":"R Wickham","year":"2006","unstructured":"Wickham R, Engelking C, Sauerland C, Corbi D (2006) Vesicant extravasation part II: evidence-based management and continuing controversies. Oncol Nurs Forum 33(6):1143\u20131150. doi: 10.1188\/06\/ONF. 1143-1150","journal-title":"Oncol Nurs Forum"},{"issue":"11","key":"2635_CR37","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1200\/JCO.1988.6.11.1732","volume":"6","author":"IN Olver","year":"1988","unstructured":"Olver IN, Aisner J, Hament A, Buchanan L, Bishop JF, Kaplan RS (1988) A prospective study of topical dimethyl sulfoxide for treating anthracycline extravasation. J Clin Oncol 6(11):1732\u20131735","journal-title":"J Clin Oncol"},{"issue":"4","key":"2635_CR38","first-page":"693","volume":"18","author":"DS Alberts","year":"1991","unstructured":"Alberts DS, Dorr RT (1991) Case report: topical DMSO for mitomycin-C-induced skin ulceration. Oncol Nurs Forum 18(4):693\u2013695","journal-title":"Oncol Nurs Forum"},{"issue":"3","key":"2635_CR39","doi-asserted-by":"crossref","first-page":"385","DOI":"10.2165\/00003495-199856030-00009","volume":"56","author":"LR Wiseman","year":"1998","unstructured":"Wiseman LR, Spencer CM (1998) Dexrazoxane. A review of its use as a cardioprotective agent in patients receiving anthracycline-based chemotherapy. Drugs 56(3):385\u2013403","journal-title":"Drugs"},{"issue":"3","key":"2635_CR40","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1093\/annonc\/mdl413","volume":"18","author":"HT Mouridsen","year":"2007","unstructured":"Mouridsen HT, Langer SW, Buter J, Eidtmann H, Rosti G, de Wit M, Knoblauch P, Rasmussen A, Dahlstrom K, Jensen PB, Giaccone G (2007) Treatment of anthracycline extravasation with Savene (dexrazoxane): results from two prospective clinical multicentre studies. Ann Oncol 18(3):546\u2013550. doi: 10.1093\/annonc\/mdl413","journal-title":"Ann Oncol"},{"issue":"5","key":"2635_CR41","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1007\/s00520-012-1382-2","volume":"20","author":"C Fontaine","year":"2012","unstructured":"Fontaine C, Noens L, Pierre P, De Greve J (2012) Savene(R) (dexrazoxane) use in clinical practice. Support Care Cancer 20(5):1109\u20131112. doi: 10.1007\/s00520-012-1382-2","journal-title":"Support Care Cancer"},{"issue":"4","key":"2635_CR42","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1007\/s11912-010-0110-7","volume":"12","author":"SW Langer","year":"2010","unstructured":"Langer SW (2010) Extravasation of chemotherapy. Curr Oncol Rep 12(4):242\u2013246. doi: 10.1007\/s11912-010-0110-7","journal-title":"Curr Oncol Rep"},{"issue":"1","key":"2635_CR43","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s00280-005-0022-7","volume":"57","author":"SW Langer","year":"2006","unstructured":"Langer SW, Thougaard AV, Sehested M, Jensen PB (2006) Treatment of anthracycline extravasation in mice with dexrazoxane with or without DMSO and hydrocortisone. Cancer Chemother Pharmacol 57(1):125\u2013128. doi: 10.1007\/s00280-005-0022-7","journal-title":"Cancer Chemother Pharmacol"},{"issue":"8","key":"2635_CR44","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1007\/BF01191807","volume":"120","author":"G Bertelli","year":"1994","unstructured":"Bertelli G, Dini D, Forno GB, Gozza A, Silvestro S, Venturini M, Rosso R, Pronzato P (1994) Hyaluronidase as an antidote to extravasation of Vinca alkaloids: clinical results. J Cancer Res Clin Oncol 120(8):505\u2013506","journal-title":"J Cancer Res Clin Oncol"},{"issue":"5","key":"2635_CR45","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1007\/s00520-003-0441-0","volume":"11","author":"BL Stanford","year":"2003","unstructured":"Stanford BL, Hardwicke F (2003) A review of clinical experience with paclitaxel extravasations. Support Care Cancer 11(5):270\u2013277. doi: 10.1007\/s00520-003-0441-0","journal-title":"Support Care Cancer"},{"issue":"5","key":"2635_CR46","doi-asserted-by":"crossref","first-page":"973","DOI":"10.3892\/or.3.5.973","volume":"3","author":"A Dubois","year":"1996","unstructured":"Dubois A, Fehr M, Bochtler H, Koechli O (1996) Clinical course and management of paclitaxel extravasation. Oncol Rep 3(5):973\u2013974","journal-title":"Oncol Rep"},{"issue":"11","key":"2635_CR47","doi-asserted-by":"crossref","first-page":"2266","DOI":"10.1002\/(SICI)1097-0142(19970701)79:11<2266::AID-CNCR30>3.0.CO;2-R","volume":"79","author":"G Bertelli","year":"1997","unstructured":"Bertelli G, Cafferata MA, Ardizzoni A, Gozza A, Rosso R, Dini D (1997) Skin ulceration potential of paclitaxel in a mouse skin model in vivo. Cancer 79(11):2266\u20132269. doi: 10.1002\/(SICI)1097-0142(19970701)79","journal-title":"Cancer"},{"issue":"21","key":"2635_CR48","doi-asserted-by":"crossref","first-page":"4068","DOI":"10.1200\/JCO.2003.99.095","volume":"21","author":"A Kretzschmar","year":"2003","unstructured":"Kretzschmar A, Pink D, Thuss-Patience P, Dorken B, Reichert P, Eckert R (2003) Extravasations of oxaliplatin. J Clin Oncol 21(21):4068\u20134069. doi: 10.1200\/JCO.2003.99.095JCO.2003.99.095","journal-title":"J Clin Oncol"},{"issue":"3","key":"2635_CR49","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1177\/030089160909500301","volume":"95","author":"SW Langer","year":"2009","unstructured":"Langer SW, Sehested M, Jensen PB (2009) Anthracycline extravasation: a comprehensive review of experimental and clinical treatments. Tumori 95(3):273\u2013282","journal-title":"Tumori"},{"issue":"1","key":"2635_CR50","first-page":"113","volume":"74","author":"RT Dorr","year":"1985","unstructured":"Dorr RT, Alberts DS (1985) Vinca alkaloid skin toxicity: antidote and drug disposition studies in the mouse. J Natl Cancer Inst 74(1):113\u2013120","journal-title":"J Natl Cancer Inst"},{"issue":"4","key":"2635_CR51","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1007\/BF00686305","volume":"30","author":"NB Tsavaris","year":"1992","unstructured":"Tsavaris NB, Komitsopoulou P, Karagiaouris P, Loukatou P, Tzannou I, Mylonakis N, Kosmidis P (1992) Prevention of tissue necrosis due to accidental extravasation of cytostatic drugs by a conservative approach. Cancer Chemother Pharmacol 30(4):330\u2013333","journal-title":"Cancer Chemother Pharmacol"},{"issue":"1","key":"2635_CR52","first-page":"57","volume":"22","author":"DM Boyle","year":"1995","unstructured":"Boyle DM, Engelking C (1995) Vesicant extravasation: myths and realities. Oncol Nurs Forum 22(1):57\u201367","journal-title":"Oncol Nurs Forum"},{"issue":"3","key":"2635_CR53","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/S0094-1298(20)31322-5","volume":"16","author":"FR Heckler","year":"1989","unstructured":"Heckler FR (1989) Current thoughts on extravasation injuries. Clin Plast Surg 16(3):557\u2013563","journal-title":"Clin Plast Surg"},{"issue":"3","key":"2635_CR54","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/S0363-5023(86)80147-2","volume":"11","author":"TS Loth","year":"1986","unstructured":"Loth TS, Eversmann WW Jr (1986) Treatment methods for extravasations of chemotherapeutic agents: a comparative study. J Hand Surg Am 11(3):388\u2013396","journal-title":"J Hand Surg Am"},{"issue":"7","key":"2635_CR55","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1200\/JCO.1987.5.7.1116","volume":"5","author":"R Rudolph","year":"1987","unstructured":"Rudolph R, Larson DL (1987) Etiology and treatment of chemotherapeutic agent extravasation injuries: a review. J Clin Oncol 5(7):1116\u20131126","journal-title":"J Clin Oncol"},{"issue":"1","key":"2635_CR56","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1097\/00000637-199401000-00008","volume":"32","author":"N Scuderi","year":"1994","unstructured":"Scuderi N, Onesti MG (1994) Antitumor agents: extravasation, management, and surgical treatment. Ann Plast Surg 32(1):39\u201344","journal-title":"Ann Plast Surg"},{"issue":"1","key":"2635_CR57","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1188\/13.CJON.61-66","volume":"17","author":"T Gonzalez","year":"2013","unstructured":"Gonzalez T (2013) Chemotherapy extravasations: prevention, identification, management, and documentation. Clin J Oncol Nurs 17(1):61\u201366. doi: 10.1188\/13.CJON.61-66PRX1P674584LK1N0","journal-title":"Clin J Oncol Nurs"},{"key":"2635_CR58","unstructured":"ONS (2009) Chemotherapy and biotherapy guidelines and recommendations for practice (3rd ed.). 376 p"},{"key":"2635_CR59","doi-asserted-by":"crossref","unstructured":"Atallah E, Salomon, M, Schiffer, C.A. et El-Rayes, B (2006) The role of venography in the evaluation of malfunctioning central venous access ports (CVAPs). Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 24 (18S Abstract 18535)","DOI":"10.1200\/jco.2006.24.18_suppl.18535"},{"issue":"4","key":"2635_CR60","first-page":"707","volume":"22","author":"CN Rittenberg","year":"1995","unstructured":"Rittenberg CN, Gralla RJ, Rehmeyer TA (1995) Assessing and managing venous irritation associated with vinorelbine tartrate (Navelbine). Oncol Nurs Forum 22(4):707\u2013710","journal-title":"Oncol Nurs Forum"},{"key":"2635_CR61","unstructured":"Biocodex inc (2011) Monographie Totect. Mai 2011. Accessed 2 August 2013"},{"key":"2635_CR62","unstructured":"Polovich M., White, J., & Kelleher, L. (Eds.). Chemotherapy and biotherapy guidelines and recommendations for practice (2nd ed.). Pittsburgh, PA: Oncology Nursing Society"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-015-2635-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00520-015-2635-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-015-2635-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,30]],"date-time":"2022-04-30T13:26:31Z","timestamp":1651325191000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00520-015-2635-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2,26]]},"references-count":62,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,5]]}},"alternative-id":["2635"],"URL":"https:\/\/doi.org\/10.1007\/s00520-015-2635-7","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,2,26]]}}}